Non‐Randomized Clinical Trial of a Short‐Term Therapy Group for Adults Diagnosed With Borderline Personality Disorder: An Intermediate Step in Care
Journal of Clinical Psychology · 2025
DOI: 10.1002/jclp.70002 ↗Kurz gefasst
Pragmatische Studie in der Zeitschrift Journal of Clinical Psychology, 2025. Verfasst von Dianna R Bartsch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Borderline Personality Disorder Collaborative, SA Health, Barossa Hills Fleurieu Local Health Network (BHF LHN), Unley, South Australia, Australia. Hauptthemen laut MEDLINE: Borderline Personality Disorder, Psychotherapy, Group, Psychotherapy, Brief, Outcome Assessment, Health Care. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objective
The aim of this study was to evaluate the effectiveness of Road Maps, a short‐term therapy group program (i.e., 12 weeks) as part of an intermediate step in care for adults with a diagnosis of borderline personality disorder (BPD).
Method
A pragmatic non‐randomized clinical trial study design was utilized to examine the effectiveness of Road Maps in a publicly funded community mental health care setting. First, we examined whether participation in the short‐term group intervention ( n = 80) resulted in significantly greater reductions in psychopathology and improved psychosocial functioning compared to waiting for the intervention ( n = 41). The waitlist condition was naturalistic (> 28 days) in that there was no specific allocation to conditions and all people on the waitlist had the opportunity to participate in the next available group. Second, we examined whether therapeutic gains were maintained at 6‐month follow‐up across the entire sample ( N = 121). Finally, we analysed the proportion of respondents who demonstrated clinically significant change.
Results
Relative to people on the waitlist for the intervention, those who participated in the group demonstrated a significantly greater reduction in the primary outcomes of borderline symptom severity and personality dysfunction (e.g., both self and interpersonal functioning) and secondary outcomes (e.g., emotion regulation, reflective functioning, and psychosocial functioning). Therapeutic gains were maintained at 6‐month follow‐up.
Conclusion
Short‐term therapy groups such as Road Maps may be a useful intermediate step in a broader model of stepped care aimed at increasing treatment accessibility in resource‐constrained environments. Trial Registration Australian New Zealand Clinical Trials Registry ACTRN12622000849796/retrospectively registered 16th June 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Borderline Personality Disorder Collaborative, SA Health, Barossa Hills Fleurieu Local Health Network (BHF LHN), Unley, South Australia, Australia.
- School of Psychology, The University of Adelaide, Adelaide, South Australia, Australia.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Bartsch, D. R., Cooke-O'connor, L., Connerty, T., Dahlenburg, S. C., & Cammell, P. (2025). Non‐Randomized Clinical Trial of a Short‐Term Therapy Group for Adults Diagnosed With Borderline Personality Disorder: An Intermediate Step in Care. Journal of Clinical Psychology. https://doi.org/10.1002/jclp.70002
Vancouver
Bartsch DR, Cooke-O'connor L, Connerty T, Dahlenburg SC, Cammell P. Non‐Randomized Clinical Trial of a Short‐Term Therapy Group for Adults Diagnosed With Borderline Personality Disorder: An Intermediate Step in Care. Journal of Clinical Psychology. 2025. doi:10.1002/jclp.70002
BibTeX
@article{Bartsch2025,
author = {Bartsch, Dianna R and Cooke-O'connor, Laura and Connerty, Tracy and Dahlenburg, Sophie C and Cammell, Paul},
title = {Non‐Randomized Clinical Trial of a Short‐Term Therapy Group for Adults Diagnosed With Borderline Personality Disorder: An Intermediate Step in Care},
journal = {Journal of Clinical Psychology},
year = {2025},
doi = {10.1002/jclp.70002}
}
EUVIMED